Characterization of a Novel Hepatitis C Virus Genotype 1 Subtype from a Patient Failing 4 Weeks of Glecaprevir-Pibrentasvir Treatment

por Pedersen, Martin S., Fahnøe, Ulrik, Madsen, Lone W., Christensen, Peer B., Øvrehus, Anne, Bukh, Jens
Publicado 2021

Viral dynamics of SARS-CoV-2 in immunocompromised patients

por Utzon, Andrea N., Johansen, Isik S., Bang, Line L., Pedersen, Rune M., Andersen, Thomas E., Madsen, Lone W.
Publicado 2023

Four Weeks Treatment with Glecaprevir/Pibrentasvir + Ribavirin—A Randomized Controlled Clinical Trial

por Madsen, Lone W., Christensen, Peer B., Hansen, Janne F., Røge, Birgit T., Holm, Dorte K., Dröse, Sandra, Øvrehus, Anne
Publicado 2022

Rectally shed SARS-CoV-2 lacks infectivity: time to rethink faecal–oral transmission?

por Pedersen, Rune M., Tornby, Ditte S., Bang, Line L., Madsen, Lone W., Skov, Marianne N., Jensen, Thøger G., Johansen, Isik S., Andersen, Thomas E.
Publicado 2021

Serum Neutralization of SARS-CoV-2 Omicron BA.1 and BA.2 after BNT162b2 Booster Vaccination

por Pedersen, Rune M., Bang, Line L., Madsen, Lone W., Sydenham, Thomas V., Johansen, Isik S., Jensen, Thøger G., Justesen, Ulrik S., Andersen, Thomas E.
Publicado 2022

Serum Neutralization of Omicron XBB.1.5 in Kidney Transplant Recipients After Bivalent mRNA Booster Vaccination

por Pedersen, Rune M., Bang, Line L., Holm, Dorte K., Madsen, Lone W., Johansen, Isik S., Jensen, Thøger G., Justesen, Ulrik S., Bistrup, Claus, Andersen, Thomas E.
Publicado 2023

Omicron BA.5 Neutralization among Vaccine-Boosted Persons with Prior Omicron BA.1/BA.2 Infections

por Pedersen, Rune M., Bang, Line L., Tornby, Ditte S., Madsen, Lone W., Holm, Dorte K., Sydenham, Thomas V., Johansen, Isik S., Jensen, Thøger G., Justesen, Ulrik S., Andersen, Thomas E.
Publicado 2022

Serum Neutralization of Omicron BA.5, BA.2 and BA.1 in Triple Vaccinated Kidney Transplant Recipients

por Pedersen, Rune M., Bang, Line L., Tornby, Ditte S., Nilsson, Anna C., Nielsen, Christian, Madsen, Lone W., Johansen, Isik S., Sydenham, Thomas V., Jensen, Thøger G., Justesen, Ulrik S., Vitved, Lars, Palarasah, Yaseelan, Bistrup, Claus, Andersen, Thomas E.
Publicado 2022

Omicron Variant-Specific Serological Imprinting Following BA.1 or BA.4/5 Bivalent Vaccination and Previous SARS-CoV-2 Infection: A Cohort Study

por Baerends, Eva A M, Reekie, Joanne, Andreasen, Signe R, Stærke, Nina B, Raben, Dorthe, Nielsen, Henrik, Petersen, Kristine T, Johansen, Isik S, Lindvig, Susan O, Madsen, Lone W, Wiese, Lothar, Iversen, Mette B, Benfield, Thomas, Iversen, Kasper K, Larsen, Fredrikke D, Andersen, Sidsel D, Juhl, Anna K, Dietz, Lisa L, Hvidt, Astrid K, Ostrowski, Sisse R, Krause, Tyra G, Østergaard, Lars, Søgaard, Ole S, Lundgren, Jens, Tolstrup, Martin
Publicado 2023

SARS-CoV-2 vaccine-induced antibodies protect against Omicron breakthrough infection

por Baerends, Eva A.M., Hvidt, Astrid K., Reekie, Joanne, Søgaard, Ole S., Stærke, Nina B., Raben, Dorthe, Nielsen, Henrik, Petersen, Kristine T., Juhl, Maria R., Johansen, Isik S., Lindvig, Susan O., Madsen, Lone W., Wiese, Lothar, Knudsen, Lene S., Iversen, Mette B., Benfield, Thomas, Iversen, Kasper K., Andersen, Sidsel D., Juhl, Anna K., Dietz, Lisa L., Andreasen, Signe R., Fischer, Thea K., Erikstrup, Christian, Valentiner-Branth, Palle, Lundgren, Jens, Østergaard, Lars, Tolstrup, Martin
Publicado 2023